Milestone Pharmaceuticals (MIST) Net Equity Issued and Repurchased (2020 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Net Equity Issued and Repurchased came in at $10.9 million in Q1 2026, down 24.64% on a QoQ basis from $14.4 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $10.9 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (changed N/A YoY) and the FY2025 annual result came in at $37.6 million, up 37.92% from the prior year.
- Net Equity Issued and Repurchased eased to $10.9 million in Q1 2026, from $14.4 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $27.5 million in Q1 2024 to a low of -$280000.0 in Q2 2024.
- A 4-year average of $10.5 million and a median of $10.9 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.89 Mn |
| Mar 31, 2026 | 10.89 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Jun 30, 2024 | -280,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | 27.54 Mn |
| Mar 31, 2024 | 27.54 Mn |
| Dec 31, 2022 | -14,000.00 |
| Dec 31, 2022 | -14,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Mar 31, 2020 | 77,000.00 |
| Mar 31, 2020 | 77,000.00 |